FDA Inspection 1002827 — John S. Bradley, M.D., Prinicple Investigator
The FDA completed an inspection of John S. Bradley, M.D., Prinicple Investigator on Jan 27, 2017 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Clinical Investigator (CI)